Matthew A. Downey

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Massachusetts General Hospital(Current)

AZTherapies (United States)

Harvard University

Matthew A. Downey is an author at Massachusetts General Hospital specializing in pharmacology, amyloid beta aggregation, and structure-based pharmacophore modeling.

ORCID

Publications per year

2018–2021

Publications

Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3)

Alina Monteagudo, Matthew A. Downey, Philip G. Ashton‐Rickardt et al. · Scientific Reports · 2021 · 42 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Inhibiting and Remodeling Toxic Amyloid-Beta Oligomer Formation Using a Computationally Designed Drug Molecule That Targets Alzheimer’s Disease

Matthew A. Downey, Maxwell J. Giammona, Christian A. Lang et al. · Journal of the American Society for Mass Spectrometry · 2018 · 14 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Cromolyn platform suppresses fibrosis and inflammation, promotes microglial phagocytosis and neurite outgrowth

Matthew A. Downey, Sungwoon Choi, Timothy M. Shoup et al. · Scientific Reports · 2021 · 10 citations · Full text

Life Sciences, Cell Biology, Immunology +17

1–3 of 3